1. Home
  2. FATE vs EFTY Comparison

FATE vs EFTY Comparison

Compare FATE & EFTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • EFTY
  • Stock Information
  • Founded
  • FATE 2007
  • EFTY 2013
  • Country
  • FATE United States
  • EFTY Hong Kong
  • Employees
  • FATE N/A
  • EFTY N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • EFTY
  • Sector
  • FATE Health Care
  • EFTY
  • Exchange
  • FATE Nasdaq
  • EFTY Nasdaq
  • Market Cap
  • FATE 116.5M
  • EFTY 113.6M
  • IPO Year
  • FATE 2013
  • EFTY 2025
  • Fundamental
  • Price
  • FATE $0.96
  • EFTY $8.57
  • Analyst Decision
  • FATE Hold
  • EFTY
  • Analyst Count
  • FATE 6
  • EFTY 0
  • Target Price
  • FATE $3.30
  • EFTY N/A
  • AVG Volume (30 Days)
  • FATE 1.4M
  • EFTY 356.2K
  • Earning Date
  • FATE 11-11-2025
  • EFTY 01-01-0001
  • Dividend Yield
  • FATE N/A
  • EFTY N/A
  • EPS Growth
  • FATE N/A
  • EFTY N/A
  • EPS
  • FATE N/A
  • EFTY 0.05
  • Revenue
  • FATE $8,470,000.00
  • EFTY $2,525,909.00
  • Revenue This Year
  • FATE N/A
  • EFTY N/A
  • Revenue Next Year
  • FATE N/A
  • EFTY N/A
  • P/E Ratio
  • FATE N/A
  • EFTY $175.13
  • Revenue Growth
  • FATE N/A
  • EFTY 3855.20
  • 52 Week Low
  • FATE $0.66
  • EFTY $3.88
  • 52 Week High
  • FATE $4.20
  • EFTY $8.88
  • Technical
  • Relative Strength Index (RSI)
  • FATE 40.20
  • EFTY N/A
  • Support Level
  • FATE $0.93
  • EFTY N/A
  • Resistance Level
  • FATE $1.08
  • EFTY N/A
  • Average True Range (ATR)
  • FATE 0.06
  • EFTY 0.00
  • MACD
  • FATE -0.01
  • EFTY 0.00
  • Stochastic Oscillator
  • FATE 11.22
  • EFTY 0.00

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About EFTY Etoiles Capital Group Co. Ltd. Class A Ordinary Shares

Etoiles Capital Group Co Ltd specializes in providing integrated investor relations services within the financial industry.

Share on Social Networks: